Herbas VPB

Print
EN | LT
LT - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
EN - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 5/0783 (2010.01)
A61K 39/0008 (2013.01)
A61K 39/00 (2006.01)
A61K 39/0011 (2013.01)
A61P 29/00 (2006.01)
C12N 5/0636 (2013.01)
A61P 37/00 (2006.01)
A61P 29/00 (2018.01)
A61P 37/00 (2018.01)
European patent
(11) Number of the document 3097923
(13) Kind of document T
(96) European patent application number 16177278.5
Date of filing the European patent application 2008-01-31
(97) Date of publication of the European application 2016-11-30
(45) Date of publication and mention of the grant of the patent 2022-07-27
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
898408 P 2007-01-31 US
951052 P 2007-07-20 US
Inventors
(72)
ESHHAR, Zelig , IL
ELINAV, Eran , IL
Grantee
(73) YEDA RESEARCH AND DEVELOPMENT CO., LTD. , The Weizmann Institute of Science, P.O. Box 95, 76100 Rehovot, IL
Title
(54) REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
  REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE